Claude Krummenacher

  • 3732 Citations
  • 34 h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Research Expertise:
Virology | Cell biology | Molecular and structural biology

My lab focuses on the interactions between herpes simplex virus (HSV) and its human host. To identify new therapeutic targets, we use molecular and cellular approaches to understand host-virus interactions and responses to infection. We study the mechanism by which HSV binds to cellular receptors in order to design inhibitors of virus entry. We also characterize cellular responses to identify factors involved in susceptibility to HSV infection. Finally, we also are interested in the effects of human saliva on the susceptibility to infection by HSV. This combination of approaches aims at identifying new biomarkers for HSV susceptibility and discovering novel targets for innovative antiviral targets for innovative therapies. We recently interested in identifying and developing new compounds that can inhibit HSV infection and spread.

Honors and Awards:
Joseph and Josephine Rabinowitz Award for Scientific Excellence at the PENN Dental School (2007)
Stephen L Sacks Investigator Award from the American Herpes Foundation (2005)
Frances R Lax Award for Faculty Development at Rowan University (2015)

Member of:
American Society for Microbiology (
American Association for the Advancement of Science (
American Society for Virology (

Fingerprint Dive into the research topics where Claude Krummenacher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

  • 3732 Citations
  • 34 h-Index
  • 49 Article
  • 3 Review article
  • 2 Chapter
  • 1 Editorial

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection

Zhang, X., Zhao, B., Ding, M., Song, S., Kang, Y., Yu, Y., Xu, M., Xiang, T., Gao, L., Feng, Q., Zhao, Q., Zeng, M. S., Krummenacher, C. & Zeng, Y. X., 2020, In : Theranostics. 10, 13, p. 5704-5718 15 p.

Research output: Contribution to journalArticle

Open Access
  • Herpes simplex virus 1 spread in oligodendrocytic cells is highly dependent on MAl proteolipid

    López-Guerrero, J. A., de la Nuez, C., Praena, B., Sánchez-León, E., Krummenacher, C. & Bello-Morales, R., Feb 1 2020, In : Journal of virology. 94, 4, e01739-19.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Interaction between nectin-1 and the human natural killer cell receptor CD96

    Holmes, V. M., De Motes, C. M., Richards, P. T., Roldan, J., Bhargava, A. K., Orange, J. S. & Krummenacher, C., Feb 2019, In : PloS one. 14, 2, e0212443.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    Saliva enhances infection of gingival fibroblasts by herpes simplex virus 1

    Zuo, Y., Charles Whitbeck, J., Haila, G. J., Hakim, A. A., Rothlauf, P. W., Eisenberg, R. J., Cohen, G. H. & Krummenacher, C., Oct 1 2019, In : PloS one. 14, 10, e0223299.

    Research output: Contribution to journalArticle

    Open Access
  • Immunization with Fc-based recombinant Epstein-Barr virus gp350 elicits potent neutralizing humoral immune response in a BALB/c mice model

    Zhao, B., Zhang, X., Krummenacher, C., Song, S., Gao, L., Zhang, H., Xu, M., Feng, L., Feng, Q., Zeng, M., Xu, Y. & Zeng, Y., May 1 2018, In : Frontiers in Immunology. 9, MAY, 932.

    Research output: Contribution to journalArticle

  • 10 Scopus citations